Expansion in California for Pharmaceutical R&D Services

WuXi AppTec, a phar­ma­ceu­ti­cal and med­ical device open-access capa­bil­i­ty and tech­nol­o­gy plat­form com­pa­ny with glob­al oper­a­tions, announces the expan­sion of its facil­i­ties in San Diego, California.

WuXi AppTec’s new­ly expand­ed facil­i­ty will estab­lish a cen­ter of excel­lence in screen­ing, dis­cov­ery biol­o­gy, phar­ma­col­o­gy, and small mol­e­cule process R&D includ­ing phase I GMP man­u­fac­tur­ing. The expan­sion will pro­vide key ele­ments of WuX­i’s small mol­e­cule capa­bil­i­ty and tech­nol­o­gy plat­form under one roof, fur­ther enhanc­ing ser­vices to North Amer­i­can phar­ma­ceu­ti­cal and biotech indus­tries. WuXi will also add exten­sive­ly from the local tal­ent base, fur­ther con­tribut­ing to region­al eco­nom­ic growth.

“The San Diego life sci­ence com­mu­ni­ty con­tin­ues to thrive with the com­mit­ments and invest­ments made by lead­ing inter­na­tion­al pow­er­hous­es like WuXi AppTec,” said Joe Panet­ta, pres­i­dent and CEO of Bio­com. “Their lat­est facil­i­ty expan­sion in San Diego is a tes­ta­ment to the deep rela­tion­ships they have built with the local biotech com­mu­ni­ty. Bio­com applauds the pos­i­tive impact they’ve had on the region’s eco­nom­ic growth and inno­v­a­tive health­care prod­ucts for our patients.”

“This expan­sion will enable us to bet­ter serve our U.S. and glob­al cus­tomers, and con­tribute to the growth and suc­cess of the dynam­ic San Diego biotech ecosys­tem. Togeth­er with our ecosys­tem part­ners, we will con­tin­ue to strength­en WuX­i’s capa­bil­i­ty and tech­nol­o­gy enabling plat­form to expe­dite the dis­cov­ery and devel­op­ment of new med­i­cines for patients world­wide, and for a future where every drug can be made and every dis­ease can be treated.”

Dr. Ge Li, Chair­man and CEO of WuXi AppTec